title: Treatment of membranous lupus nephritis with prednisone, azathioprine and cyclosporin A.
authors.forename: L S
authors.initials: LS
authors.lastname: Tam
authors.forename: E K
authors.initials: EK
authors.lastname: Li
authors.forename: C C
authors.initials: CC
authors.lastname: Szeto
authors.forename: S M
authors.initials: SM
authors.lastname: Wong
authors.forename: C B
authors.initials: CB
authors.lastname: Leung
authors.forename: F M
authors.initials: FM
authors.lastname: Lai
authors.forename: K C
authors.initials: KC
authors.lastname: Wong
authors.forename: S F
authors.initials: SF
authors.lastname: Lui
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001379:Azathioprine / Q000008:administration & dosage*; D016572:Cyclosporine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008181:Lupus Nephritis / Q000188:drug therapy*; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage*; D011446:Prospective Studies
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone